Literature DB >> 30882366

Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles.

Yuan Tian1, Mariana Babor1, Jerome Lane1, Grégory Seumois1, Shu Liang1, N D Suraj Goonawardhana2, Aruna D De Silva1,2, Elizabeth J Phillips3,4, Simon A Mallal3,4, Ricardo da Silva Antunes1, Alba Grifoni1, Pandurangan Vijayanand1, Daniela Weiskopf1, Bjoern Peters1,5, Alessandro Sette1,5.   

Abstract

Accumulating evidence demonstrates that CD8+ T cells contribute to protection from severe dengue virus (DENV) disease and vaccine efficacy. Nevertheless, molecular programs associated with DENV-specific CD8+ T cell subsets have not been defined. Here, we studied the transcriptomic profiles of human DENV-specific CD8+ T cells isolated after stimulation with DENV epitopes from donors who had been infected with DENV multiple times and would therefore be expected to have significant levels of adaptive immunity. We found that DENV-specific CD8+ T cells mainly consisted of effector memory subsets, namely CD45RA-CCR7- effector memory (Tem) and CD45RA+CCR7- effector memory re-expressing CD45RA (Temra) cells, which enacted specific gene expression profiles upon stimulation with cognate antigens. DENV-specific CD8+ T cell subsets in general, and Temra cells in particular, were fully activated and polyfunctional, yet associated with relatively narrow transcriptional responses. Furthermore, we found that DENV-specific CD8+ Tem and Temra cells showed some unique T cell receptor features in terms of overlap and variable (V) gene usage. This study provides a transcriptomic definition of DENV-specific activated human CD8+ T cell subsets and defines a benchmark profile that vaccine-specific responses could aim to reproduce.

Entities:  

Keywords:  Adaptive immunity; Bioinformatics; Immunology; Infectious disease; T cells

Year:  2019        PMID: 30882366      PMCID: PMC6436856          DOI: 10.1172/JCI123726

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  67 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential.

Authors:  Padraic J Dunne; Jeffery M Faint; Nancy H Gudgeon; Jean M Fletcher; Fiona J Plunkett; Maria Vieira D Soares; Andrew D Hislop; Nicola E Annels; Alan B Rickinson; Mike Salmon; Arne N Akbar
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

3.  Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization.

Authors:  Annette A Kraus; William Messer; Laura B Haymore; Aravinda M de Silva
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

4.  Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.

Authors:  John W Northfield; Christopher P Loo; Jason D Barbour; Gerald Spotts; Frederick M Hecht; Paul Klenerman; Douglas F Nixon; Jakob Michaëlsson
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection.

Authors:  Daniele Lilleri; Chiara Fornara; Maria Grazia Revello; Giuseppe Gerna
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

6.  A protective role for dengue virus-specific CD8+ T cells.

Authors:  Lauren E Yauch; Raphaël M Zellweger; Maya F Kotturi; Afrina Qutubuddin; John Sidney; Bjoern Peters; Tyler R Prestwood; Alessandro Sette; Sujan Shresta
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

Review 7.  Central memory and effector memory T cell subsets: function, generation, and maintenance.

Authors:  Federica Sallusto; Jens Geginat; Antonio Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

8.  Severe dengue epidemics in Sri Lanka, 2003-2006.

Authors:  Nalaka Kanakaratne; Wahala M P B Wahala; William B Messer; Hasitha A Tissera; Aruna Shahani; Nihal Abeysinghe; Aravinda M de-Silva; Maya Gunasekera
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

9.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

10.  WGCNA: an R package for weighted correlation network analysis.

Authors:  Peter Langfelder; Steve Horvath
Journal:  BMC Bioinformatics       Date:  2008-12-29       Impact factor: 3.169

View more
  15 in total

Review 1.  Transcriptomic immune profiles of human flavivirus-specific T-cell responses.

Authors:  Alba Grifoni; Yuan Tian; Alessandro Sette; Daniela Weiskopf
Journal:  Immunology       Date:  2020-01-07       Impact factor: 7.397

Review 2.  Epitope prediction and identification- adaptive T cell responses in humans.

Authors:  John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Semin Immunol       Date:  2020-10-31       Impact factor: 11.130

3.  Transcriptomics of Acute DENV-Specific CD8+ T Cells Does Not Support Qualitative Differences as Drivers of Disease Severity.

Authors:  Alba Grifoni; Hannah Voic; Esther Dawen Yu; Jose Mateus; Kai Mei Yan Fung; Alice Wang; Grégory Seumois; Aruna D De Silva; Rashika Tennekon; Sunil Premawansa; Gayani Premawansa; Rashmi Tippalagama; Ananda Wijewickrama; Ashu Chawla; Jason Greenbaum; Bjoern Peters; Vijayanand Pandurangan; Daniela Weiskopf; Alessandro Sette
Journal:  Vaccines (Basel)       Date:  2022-04-14

Review 4.  Protection against dengue virus requires a sustained balance of antibody and T cell responses.

Authors:  Kristen M Valentine; Michael Croft; Sujan Shresta
Journal:  Curr Opin Virol       Date:  2020-08-13       Impact factor: 7.090

Review 5.  Human T Cell Response to Dengue Virus Infection.

Authors:  Yuan Tian; Alba Grifoni; Alessandro Sette; Daniela Weiskopf
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

6.  Quantitative and Qualitative Perturbations of CD8+ MAITs in Healthy Mycobacterium tuberculosis-Infected Individuals.

Authors:  Mikhail Pomaznoy; Rebecca Kuan; Mikaela Lindvall; Julie G Burel; Grégory Seumois; Pandurangan Vijayanand; Randy Taplitz; Robert H Gilman; Mayuko Saito; David M Lewinsohn; Alessandro Sette; Bjoern Peters; Cecilia S Lindestam Arlehamn
Journal:  Immunohorizons       Date:  2020-06-04

7.  SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential.

Authors:  Jason Neidleman; Xiaoyu Luo; Julie Frouard; Guorui Xie; Gurjot Gill; Ellen S Stein; Matthew McGregor; Tongcui Ma; Ashley F George; Astrid Kosters; Warner C Greene; Joshua Vasquez; Eliver Ghosn; Sulggi Lee; Nadia R Roan
Journal:  Cell Rep Med       Date:  2020-08-19

8.  Rapid Induction and Maintenance of Virus-Specific CD8+ TEMRA and CD4+ TEM Cells Following Protective Vaccination Against Dengue Virus Challenge in Humans.

Authors:  Nancy Graham; Phil Eisenhauer; Sean A Diehl; Kristen K Pierce; Stephen S Whitehead; Anna P Durbin; Beth D Kirkpatrick; Alessandro Sette; Daniela Weiskopf; Jonathan E Boyson; Jason W Botten
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

9.  Transcriptional Profiling of CD8+ CMV-Specific T Cell Functional Subsets Obtained Using a Modified Method for Isolating High-Quality RNA From Fixed and Permeabilized Cells.

Authors:  Zachary R Healy; Kent J Weinhold; David M Murdoch
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

10.  Innate Lymphoid Cells Activation and Transcriptomic Changes in Response to Human Dengue Infection.

Authors:  Tiraput Poonpanichakul; Wilawan Chan-In; Anunya Opasawatchai; Fabien Loison; Oranart Matangkasombut; Varodom Charoensawan; Ponpan Matangkasombut
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.